Breast cancer screening lacking effectiveness

The recent Cochrane review on mammographic breast cancer screening disclosed no convincing reduction of breast cancer mortality, together with an increase in the number of aggressive treatments. Given this outcome, there no longer exists solid experimental evidence to support mass screening. In the...

Full description

Saved in:
Bibliographic Details
Published in:Nederlands tijdschrift voor geneeskunde Vol. 145; no. 46; p. 2205
Main Authors: Giard, R W, Bonneux, L G
Format: Journal Article
Language:Dutch
Published: Netherlands 17.11.2001
Subjects:
ISSN:0028-2162
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The recent Cochrane review on mammographic breast cancer screening disclosed no convincing reduction of breast cancer mortality, together with an increase in the number of aggressive treatments. Given this outcome, there no longer exists solid experimental evidence to support mass screening. In the Netherlands over 800,000 women are invited to participate in this activity yearly. Is this still justifiable? The final answer rests on the conclusions from the analyses carried out from three different perspectives. From the methodological viewpoint, a broad re-analysis is needed which also takes the long-term adverse effects of radiotherapy into account. From the tumourbiological perspective, whether 'early' diagnosis really has potential therapeutic consequences should be explored further. From a societal perspective, more detailed and balanced information is required, since expectations regarding the effect of screening are unrealistic. Given the preliminary outcomes of these analyses, there are now serious reservations as to whether continuation of screening is justified. Women should be informed about this matter promptly.
AbstractList The recent Cochrane review on mammographic breast cancer screening disclosed no convincing reduction of breast cancer mortality, together with an increase in the number of aggressive treatments. Given this outcome, there no longer exists solid experimental evidence to support mass screening. In the Netherlands over 800,000 women are invited to participate in this activity yearly. Is this still justifiable? The final answer rests on the conclusions from the analyses carried out from three different perspectives. From the methodological viewpoint, a broad re-analysis is needed which also takes the long-term adverse effects of radiotherapy into account. From the tumourbiological perspective, whether 'early' diagnosis really has potential therapeutic consequences should be explored further. From a societal perspective, more detailed and balanced information is required, since expectations regarding the effect of screening are unrealistic. Given the preliminary outcomes of these analyses, there are now serious reservations as to whether continuation of screening is justified. Women should be informed about this matter promptly.
The recent Cochrane review on mammographic breast cancer screening disclosed no convincing reduction of breast cancer mortality, together with an increase in the number of aggressive treatments. Given this outcome, there no longer exists solid experimental evidence to support mass screening. In the Netherlands over 800,000 women are invited to participate in this activity yearly. Is this still justifiable? The final answer rests on the conclusions from the analyses carried out from three different perspectives. From the methodological viewpoint, a broad re-analysis is needed which also takes the long-term adverse effects of radiotherapy into account. From the tumourbiological perspective, whether 'early' diagnosis really has potential therapeutic consequences should be explored further. From a societal perspective, more detailed and balanced information is required, since expectations regarding the effect of screening are unrealistic. Given the preliminary outcomes of these analyses, there are now serious reservations as to whether continuation of screening is justified. Women should be informed about this matter promptly.The recent Cochrane review on mammographic breast cancer screening disclosed no convincing reduction of breast cancer mortality, together with an increase in the number of aggressive treatments. Given this outcome, there no longer exists solid experimental evidence to support mass screening. In the Netherlands over 800,000 women are invited to participate in this activity yearly. Is this still justifiable? The final answer rests on the conclusions from the analyses carried out from three different perspectives. From the methodological viewpoint, a broad re-analysis is needed which also takes the long-term adverse effects of radiotherapy into account. From the tumourbiological perspective, whether 'early' diagnosis really has potential therapeutic consequences should be explored further. From a societal perspective, more detailed and balanced information is required, since expectations regarding the effect of screening are unrealistic. Given the preliminary outcomes of these analyses, there are now serious reservations as to whether continuation of screening is justified. Women should be informed about this matter promptly.
Author Giard, R W
Bonneux, L G
Author_xml – sequence: 1
  givenname: R W
  surname: Giard
  fullname: Giard, R W
  email: giardr@mcrz.nl
  organization: Medisch Centrum Rijnmond-Zuid, locatie Clara, afd. Klinische Pathologie, Postbus 9119, 3007 AC Rotterdam. giardr@mcrz.nl
– sequence: 2
  givenname: L G
  surname: Bonneux
  fullname: Bonneux, L G
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11757241$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tKxDAUQLMYcR76C9KVu0By82qWOviCATezL3ncSrVNa9IK_r2KM6uzORw4W7JKY8IV2TAGNQWuYU22pbwzJpWR-pKsOTfKgOQbQu8zujJXwaWAuSohI6YuvVW9Cx9_xLbFMHdfmLCUK3LRur7g9Yk7cnx8OO6f6eH16WV_d6CTkpyiAS-UtWgEh-gQ0SB4xdBa7UMto4MoRd1GAaCcjdIrrk1gwrSBeydgR27_s1MePxcsczN0JWDfu4TjUhoDAqzU9le8OYmLHzA2U-4Gl7-b8x_8AFldTFY
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
DocumentTitleAlternate Borstkankerscreening onvoldoende effectief
ExternalDocumentID 11757241
Genre English Abstract
Journal Article
Review
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GroupedDBID -QW
-Y2
0R~
123
29M
53G
AAYUE
ABJNI
ACGFS
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
EBS
ECM
EIF
EJD
F5P
NPM
OK1
SDH
7X8
ID FETCH-LOGICAL-p541-e72b3599e7312daeee7e2b50e996bc84da2d438fd3225a9d4b5167c037fc1ba32
IEDL.DBID 7X8
ISSN 0028-2162
IngestDate Thu Jul 10 17:09:40 EDT 2025
Thu May 23 23:02:55 EDT 2024
IsPeerReviewed false
IsScholarly true
Issue 46
Language Dutch
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-p541-e72b3599e7312daeee7e2b50e996bc84da2d438fd3225a9d4b5167c037fc1ba32
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
PMID 11757241
PQID 72329469
PQPubID 23479
ParticipantIDs proquest_miscellaneous_72329469
pubmed_primary_11757241
PublicationCentury 2000
PublicationDate 2001-Nov-17
20011117
PublicationDateYYYYMMDD 2001-11-17
PublicationDate_xml – month: 11
  year: 2001
  text: 2001-Nov-17
  day: 17
PublicationDecade 2000
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Nederlands tijdschrift voor geneeskunde
PublicationTitleAlternate Ned Tijdschr Geneeskd
PublicationYear 2001
SSID ssj0045746
Score 1.531822
SecondaryResourceType review_article
Snippet The recent Cochrane review on mammographic breast cancer screening disclosed no convincing reduction of breast cancer mortality, together with an increase in...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 2205
SubjectTerms Adult
Breast Neoplasms - diagnosis
Breast Neoplasms - epidemiology
Breast Neoplasms - prevention & control
Cost-Benefit Analysis
Female
Humans
Mammography - economics
Mammography - standards
Mass Screening - economics
Mass Screening - standards
Netherlands - epidemiology
Women's Health
Title Breast cancer screening lacking effectiveness
URI https://www.ncbi.nlm.nih.gov/pubmed/11757241
https://www.proquest.com/docview/72329469
Volume 145
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwED4VysDCQ7zKMwOrRRPbcSwhIUBUDFB16NCt8uMsIaGktIXfjy8PNsTA4kyW4lx83z2-uwO4Ru0KLgyyoeDIRMQcpjE30WtVynKHed40SXpR43Exm-lJD267WhiiVXY6sVbUvnIUI79REfp19OXuFh-MZkZRbrUdoLEBfR4NGSJ0qdlPDkFI1ZTpUPwoS2kczm82ZI0lo93_vcUe7LQ2ZHLfCH0feuX7AbAHopevE0diXCZRG0QPNeJSQhE6ejbMjVa5HcJ09DR9fGbtLAS2kCJlqDLLpdaoeJp5g4gKMyuHGN0V6wrhTeYFL4Kn-2m0F1amuXJDroJLreHZEWyWVYknkBgvUCLnwboIzzrY4FBS47WMo7E2DOCqO_o8_mqUPzAlVp-reXf4ARw3X2--aDpiUMdwqaItcPrn3jPYrllcRKRT59AP8ZLhBWy5r_XbanlZSzCu48nrN9aWqX8
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Breast+cancer+screening+lacking+effectiveness&rft.jtitle=Nederlands+tijdschrift+voor+geneeskunde&rft.au=Giard%2C+R+W&rft.au=Bonneux%2C+L+G&rft.date=2001-11-17&rft.issn=0028-2162&rft.volume=145&rft.issue=46&rft.spage=2205&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0028-2162&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0028-2162&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0028-2162&client=summon